rabbit anti sod1 Search Results


92
StressMarq sod1 (edi) antibody
Sod1 (Edi) Antibody, supplied by StressMarq, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+sod1/SOD1+(EDI)+Antibody/custom%40spc-206%4010%2E1016%2Fj%2Elabinv%2E2023%2E100299
Average 92 stars, based on 1 article reviews
sod1 (edi) antibody - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

92
Cusabio sod1
Sod1, supplied by Cusabio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+sod1/Rabbit+anti-Human+SOD1+Polyclonal+Antibody/pmc11527951-169-18-19
Average 92 stars, based on 1 article reviews
sod1 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

90
Rockland Immunochemicals superoxide dismutase rabbit
Impact of adropin on <t>superoxide</t> <t>dismutase</t> expression in pancreatic β‐cells of normoglycemic and diabetic rats. (A) Immunofluorescence labeling with anti‐superoxide dismutase antibody and anti‐insulin antibodies showed expression of superoxide dismutase in pancreatic β‐cells. (B) Quantification of the histological analysis showed a significant (*** p < 0.001) decrease in superoxide dismutase distribution in pancreatic endocrine cells and a significant (**** p < 0.0001) decrease in its localization in β‐cells of rats with diabetes when compared to the normal group. n = 6. Scale bar: 50 μm. Data analysis was done using the ANOVA test.
Superoxide Dismutase Rabbit, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+sod1/Superoxide+Dismutase+Antibody+Peroxidase+Conjugated/pmc12884442-8-0-5
Average 90 stars, based on 1 article reviews
superoxide dismutase rabbit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Enzo Biochem sod-1
Impact of adropin on <t>superoxide</t> <t>dismutase</t> expression in pancreatic β‐cells of normoglycemic and diabetic rats. (A) Immunofluorescence labeling with anti‐superoxide dismutase antibody and anti‐insulin antibodies showed expression of superoxide dismutase in pancreatic β‐cells. (B) Quantification of the histological analysis showed a significant (*** p < 0.001) decrease in superoxide dismutase distribution in pancreatic endocrine cells and a significant (**** p < 0.0001) decrease in its localization in β‐cells of rats with diabetes when compared to the normal group. n = 6. Scale bar: 50 μm. Data analysis was done using the ANOVA test.
Sod 1, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+sod1/rabbit+anti+sod1/pmc04493911-110-21-22
Average 90 stars, based on 1 article reviews
sod-1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Affinity Biosciences sod-1 (1:1500, af5198)
Impact of adropin on <t>superoxide</t> <t>dismutase</t> expression in pancreatic β‐cells of normoglycemic and diabetic rats. (A) Immunofluorescence labeling with anti‐superoxide dismutase antibody and anti‐insulin antibodies showed expression of superoxide dismutase in pancreatic β‐cells. (B) Quantification of the histological analysis showed a significant (*** p < 0.001) decrease in superoxide dismutase distribution in pancreatic endocrine cells and a significant (**** p < 0.0001) decrease in its localization in β‐cells of rats with diabetes when compared to the normal group. n = 6. Scale bar: 50 μm. Data analysis was done using the ANOVA test.
Sod 1 (1:1500, Af5198), supplied by Affinity Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+sod1/rabbit+anti+sod1/pmc10476536-64-10-38
Average 90 stars, based on 1 article reviews
sod-1 (1:1500, af5198) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Stressgen Biotechnologies anti sod 1, 2, and 3 rabbit polyclonal antibodies
Impact of adropin on <t>superoxide</t> <t>dismutase</t> expression in pancreatic β‐cells of normoglycemic and diabetic rats. (A) Immunofluorescence labeling with anti‐superoxide dismutase antibody and anti‐insulin antibodies showed expression of superoxide dismutase in pancreatic β‐cells. (B) Quantification of the histological analysis showed a significant (*** p < 0.001) decrease in superoxide dismutase distribution in pancreatic endocrine cells and a significant (**** p < 0.0001) decrease in its localization in β‐cells of rats with diabetes when compared to the normal group. n = 6. Scale bar: 50 μm. Data analysis was done using the ANOVA test.
Anti Sod 1, 2, And 3 Rabbit Polyclonal Antibodies, supplied by Stressgen Biotechnologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+sod1/anti+sod+1++2++and+3+rabbit+polyclonal+antibodies/10__1165_slash_rcmb__2008___0330oc-63-14-18
Average 90 stars, based on 1 article reviews
anti sod 1, 2, and 3 rabbit polyclonal antibodies - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Signalway Antibody rabbit polyclonal anti-sod1
Impact of adropin on <t>superoxide</t> <t>dismutase</t> expression in pancreatic β‐cells of normoglycemic and diabetic rats. (A) Immunofluorescence labeling with anti‐superoxide dismutase antibody and anti‐insulin antibodies showed expression of superoxide dismutase in pancreatic β‐cells. (B) Quantification of the histological analysis showed a significant (*** p < 0.001) decrease in superoxide dismutase distribution in pancreatic endocrine cells and a significant (**** p < 0.0001) decrease in its localization in β‐cells of rats with diabetes when compared to the normal group. n = 6. Scale bar: 50 μm. Data analysis was done using the ANOVA test.
Rabbit Polyclonal Anti Sod1, supplied by Signalway Antibody, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+sod1/rabbit+polyclonal+anti+sod1/pm36232201-98-45-50
Average 90 stars, based on 1 article reviews
rabbit polyclonal anti-sod1 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Medizinische Hochschule Hannover anti-rat-sod1 [cuzn (copper/zinc)-sod (superoxide dismutase)] rabbit sera
Impact of adropin on <t>superoxide</t> <t>dismutase</t> expression in pancreatic β‐cells of normoglycemic and diabetic rats. (A) Immunofluorescence labeling with anti‐superoxide dismutase antibody and anti‐insulin antibodies showed expression of superoxide dismutase in pancreatic β‐cells. (B) Quantification of the histological analysis showed a significant (*** p < 0.001) decrease in superoxide dismutase distribution in pancreatic endocrine cells and a significant (**** p < 0.0001) decrease in its localization in β‐cells of rats with diabetes when compared to the normal group. n = 6. Scale bar: 50 μm. Data analysis was done using the ANOVA test.
Anti Rat Sod1 [Cuzn (Copper/Zinc) Sod (Superoxide Dismutase)] Rabbit Sera, supplied by Medizinische Hochschule Hannover, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+sod1/anti+rat+sod1++cuzn++copper+zinc++sod++superoxide+dismutase+++rabbit+sera/10__1042_slash_cs20110665-37-0-13
Average 90 stars, based on 1 article reviews
anti-rat-sod1 [cuzn (copper/zinc)-sod (superoxide dismutase)] rabbit sera - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
StressMarq anti-sod (cu/zn) antibody
Impact of adropin on <t>superoxide</t> <t>dismutase</t> expression in pancreatic β‐cells of normoglycemic and diabetic rats. (A) Immunofluorescence labeling with anti‐superoxide dismutase antibody and anti‐insulin antibodies showed expression of superoxide dismutase in pancreatic β‐cells. (B) Quantification of the histological analysis showed a significant (*** p < 0.001) decrease in superoxide dismutase distribution in pancreatic endocrine cells and a significant (**** p < 0.0001) decrease in its localization in β‐cells of rats with diabetes when compared to the normal group. n = 6. Scale bar: 50 μm. Data analysis was done using the ANOVA test.
Anti Sod (Cu/Zn) Antibody, supplied by StressMarq, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+sod1/Anti-SOD+(Cu%2FZn)+Antibody/stressmarq___spc-115
Average 90 stars, based on 1 article reviews
anti-sod (cu/zn) antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

86
Cambridge Bioscience rabbit anti sod1 antibody
ATRX-deficient cells are highly sensitive to silencing of <t>SOD1</t> gene expression. (A) Cell viability of both HeLa LT ATRX-WT and ATRX Δ1 cells was decreased upon silencing of SOD1 ; the effect was significantly greater in the cells lacking ATRX. The effect was ameliorated upon co-treatment with NAC. (B) Testing of a panel of ALT-positive osteosarcoma cell lines showed that cell viability was significantly reduced upon silencing of SOD1 gene expression and this was largely reversed upon co-treatment with NAC. Significance was tested for average of the 3 cell lines, to give an overall significance of treatment in ALT-positive sarcomas. (C) Testing of MG63, an ALT-negative (telomerase positive) osteosarcoma cell line showed that, whilst cell viability was significantly reduced upon silencing of SOD1 gene expression, the effect was much milder than that observed in the ALT-positive cell panel. In all panels, cell viability (measured via cell titre Glo) is normalised to shControl (shSCR). Error bars represent standard deviation.
Rabbit Anti Sod1 Antibody, supplied by Cambridge Bioscience, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+sod1/anti+rabbit+sod1/pmc12449190-144-18-21
Average 86 stars, based on 1 article reviews
rabbit anti sod1 antibody - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

N/A
Rabbit anti-Mouse Sod1 Polyclonal Antibody
  Buy from Supplier

N/A
Rabbit anti-Human SOD1 Polyclonal Antibody
  Buy from Supplier

Image Search Results


Impact of adropin on superoxide dismutase expression in pancreatic β‐cells of normoglycemic and diabetic rats. (A) Immunofluorescence labeling with anti‐superoxide dismutase antibody and anti‐insulin antibodies showed expression of superoxide dismutase in pancreatic β‐cells. (B) Quantification of the histological analysis showed a significant (*** p < 0.001) decrease in superoxide dismutase distribution in pancreatic endocrine cells and a significant (**** p < 0.0001) decrease in its localization in β‐cells of rats with diabetes when compared to the normal group. n = 6. Scale bar: 50 μm. Data analysis was done using the ANOVA test.

Journal: Animal Models and Experimental Medicine

Article Title: Adropin modulates pancreatic cell proliferation and glutathione levels in an animal model of type 1 diabetes mellitus

doi: 10.1002/ame2.70092

Figure Lengend Snippet: Impact of adropin on superoxide dismutase expression in pancreatic β‐cells of normoglycemic and diabetic rats. (A) Immunofluorescence labeling with anti‐superoxide dismutase antibody and anti‐insulin antibodies showed expression of superoxide dismutase in pancreatic β‐cells. (B) Quantification of the histological analysis showed a significant (*** p < 0.001) decrease in superoxide dismutase distribution in pancreatic endocrine cells and a significant (**** p < 0.0001) decrease in its localization in β‐cells of rats with diabetes when compared to the normal group. n = 6. Scale bar: 50 μm. Data analysis was done using the ANOVA test.

Article Snippet: Superoxide dismutase (rabbit) (1:500) , Rockland Immunochemicals, USA.

Techniques: Expressing, Immunofluorescence, Labeling

Effect of adropin on superoxide dismutase expression in pancreatic α‐cells of normal and diabetic rats. (A) Immunofluorescence staining using anti‐superoxide dismutase and anti‐glucagon antibodies showed expression of superoxide dismutase in pancreatic α‐cells. (B) Quantification of the histological analysis showed a significant (** p < 0.01) decrease in superoxide dismutase distribution in the pancreatic endocrine cells of diabetic rats compared to the normal group. α‐Cell expression of superoxide dismutase did not change with adropin treatment among all groups. n = 6. Scale bar: 50 μm. Data analysis was done using the ANOVA test.

Journal: Animal Models and Experimental Medicine

Article Title: Adropin modulates pancreatic cell proliferation and glutathione levels in an animal model of type 1 diabetes mellitus

doi: 10.1002/ame2.70092

Figure Lengend Snippet: Effect of adropin on superoxide dismutase expression in pancreatic α‐cells of normal and diabetic rats. (A) Immunofluorescence staining using anti‐superoxide dismutase and anti‐glucagon antibodies showed expression of superoxide dismutase in pancreatic α‐cells. (B) Quantification of the histological analysis showed a significant (** p < 0.01) decrease in superoxide dismutase distribution in the pancreatic endocrine cells of diabetic rats compared to the normal group. α‐Cell expression of superoxide dismutase did not change with adropin treatment among all groups. n = 6. Scale bar: 50 μm. Data analysis was done using the ANOVA test.

Article Snippet: Superoxide dismutase (rabbit) (1:500) , Rockland Immunochemicals, USA.

Techniques: Expressing, Immunofluorescence, Staining

Effect of adropin on catalase, superoxide dismutase and total glutathione activities in the serum samples of healthy and diabetic rats. (A) Catalase activity was significantly decreased in diabetic rats compared to normal controls. Adropin slightly increased catalase in DMT group. (B) Superoxide dismutase was slightly increased in DMT compared to the diabetic treated with adropin. (C) Total glutathione was significantly raised with adropin treatment in DMT compared to DMUT. n = 4–6. Data analysis was done using the ANOVA test. * p < 0.05.

Journal: Animal Models and Experimental Medicine

Article Title: Adropin modulates pancreatic cell proliferation and glutathione levels in an animal model of type 1 diabetes mellitus

doi: 10.1002/ame2.70092

Figure Lengend Snippet: Effect of adropin on catalase, superoxide dismutase and total glutathione activities in the serum samples of healthy and diabetic rats. (A) Catalase activity was significantly decreased in diabetic rats compared to normal controls. Adropin slightly increased catalase in DMT group. (B) Superoxide dismutase was slightly increased in DMT compared to the diabetic treated with adropin. (C) Total glutathione was significantly raised with adropin treatment in DMT compared to DMUT. n = 4–6. Data analysis was done using the ANOVA test. * p < 0.05.

Article Snippet: Superoxide dismutase (rabbit) (1:500) , Rockland Immunochemicals, USA.

Techniques: Activity Assay

ATRX-deficient cells are highly sensitive to silencing of SOD1 gene expression. (A) Cell viability of both HeLa LT ATRX-WT and ATRX Δ1 cells was decreased upon silencing of SOD1 ; the effect was significantly greater in the cells lacking ATRX. The effect was ameliorated upon co-treatment with NAC. (B) Testing of a panel of ALT-positive osteosarcoma cell lines showed that cell viability was significantly reduced upon silencing of SOD1 gene expression and this was largely reversed upon co-treatment with NAC. Significance was tested for average of the 3 cell lines, to give an overall significance of treatment in ALT-positive sarcomas. (C) Testing of MG63, an ALT-negative (telomerase positive) osteosarcoma cell line showed that, whilst cell viability was significantly reduced upon silencing of SOD1 gene expression, the effect was much milder than that observed in the ALT-positive cell panel. In all panels, cell viability (measured via cell titre Glo) is normalised to shControl (shSCR). Error bars represent standard deviation.

Journal: Human Molecular Genetics

Article Title: Silencing of SOD1 sensitises ATRX -deficient cells to camptothecin treatment through increased activity of the alternative lengthening of telomeres pathway

doi: 10.1093/hmg/ddaf118

Figure Lengend Snippet: ATRX-deficient cells are highly sensitive to silencing of SOD1 gene expression. (A) Cell viability of both HeLa LT ATRX-WT and ATRX Δ1 cells was decreased upon silencing of SOD1 ; the effect was significantly greater in the cells lacking ATRX. The effect was ameliorated upon co-treatment with NAC. (B) Testing of a panel of ALT-positive osteosarcoma cell lines showed that cell viability was significantly reduced upon silencing of SOD1 gene expression and this was largely reversed upon co-treatment with NAC. Significance was tested for average of the 3 cell lines, to give an overall significance of treatment in ALT-positive sarcomas. (C) Testing of MG63, an ALT-negative (telomerase positive) osteosarcoma cell line showed that, whilst cell viability was significantly reduced upon silencing of SOD1 gene expression, the effect was much milder than that observed in the ALT-positive cell panel. In all panels, cell viability (measured via cell titre Glo) is normalised to shControl (shSCR). Error bars represent standard deviation.

Article Snippet: Superoxide dismutase 1 (SOD1) mouse antibody (Santa Cruz sc-17 767, 1:200), mouse anti-tubulin antibody (Abcam ab4074, 1:50000), and rabbit anti-SOD1 antibody (Cambridge Bioscience A303-812A, 1:500) were the primary antibodies utilised.

Techniques: Gene Expression, Standard Deviation

Silencing of SOD1 and camptothecin have a synergistic effect in ATRX-mutant cells. (A) Cell titre glo viability assay showed that pre-treatment with shSOD1 reduced the IC50 of CPT in ATRX-null cells, without affecting ATRX-WT cells ( p = 0.0084). This confirms the hypothesis that pre-treatment with shSOD1 can be used to sensitise ATRX-deficient cells to CPT chemotherapy. (B) Analysis by four methods demonstrated that there was no significant synergy between shSOD1 and CPT treatment in ATRX-WT cells, with mean value not meeting the threshold of > 5 (non-threshold, nt). (C) Analysis found that there was modest, but significant synergy between shSOD1 and CPT treatment in ATRX-null cells, with mean value meeting the threshold of > 5 across all four tests. (D) Western blot showing successful knockdown of SOD1 in U2OS cells using shRNA lentiviral transduction. (E) Representative image of a clonogenic survival assay showing that there is an increased effect of CPT when this is combined with SOD1 knockdown. (F) Quantification of clonogenic survival assay in U2OS cells treated with CPT for 14 days, demonstrating a trend towards significant combinatorial effect ( p = 0.06 at 10 nM CPT). Error bars represent the standard deviation (SD) across two biological replicates, each with two technical replicates; data normalised to shControl of each biological replicate. (G) Hypothetical framework for the use of hyper-ALT as a novel therapeutic approach in ALT-positive cancer cells.

Journal: Human Molecular Genetics

Article Title: Silencing of SOD1 sensitises ATRX -deficient cells to camptothecin treatment through increased activity of the alternative lengthening of telomeres pathway

doi: 10.1093/hmg/ddaf118

Figure Lengend Snippet: Silencing of SOD1 and camptothecin have a synergistic effect in ATRX-mutant cells. (A) Cell titre glo viability assay showed that pre-treatment with shSOD1 reduced the IC50 of CPT in ATRX-null cells, without affecting ATRX-WT cells ( p = 0.0084). This confirms the hypothesis that pre-treatment with shSOD1 can be used to sensitise ATRX-deficient cells to CPT chemotherapy. (B) Analysis by four methods demonstrated that there was no significant synergy between shSOD1 and CPT treatment in ATRX-WT cells, with mean value not meeting the threshold of > 5 (non-threshold, nt). (C) Analysis found that there was modest, but significant synergy between shSOD1 and CPT treatment in ATRX-null cells, with mean value meeting the threshold of > 5 across all four tests. (D) Western blot showing successful knockdown of SOD1 in U2OS cells using shRNA lentiviral transduction. (E) Representative image of a clonogenic survival assay showing that there is an increased effect of CPT when this is combined with SOD1 knockdown. (F) Quantification of clonogenic survival assay in U2OS cells treated with CPT for 14 days, demonstrating a trend towards significant combinatorial effect ( p = 0.06 at 10 nM CPT). Error bars represent the standard deviation (SD) across two biological replicates, each with two technical replicates; data normalised to shControl of each biological replicate. (G) Hypothetical framework for the use of hyper-ALT as a novel therapeutic approach in ALT-positive cancer cells.

Article Snippet: Superoxide dismutase 1 (SOD1) mouse antibody (Santa Cruz sc-17 767, 1:200), mouse anti-tubulin antibody (Abcam ab4074, 1:50000), and rabbit anti-SOD1 antibody (Cambridge Bioscience A303-812A, 1:500) were the primary antibodies utilised.

Techniques: Mutagenesis, Viability Assay, Western Blot, Knockdown, shRNA, Transduction, Clonogenic Cell Survival Assay, Standard Deviation